nemezid
sandoz gmbh - azitromicina - azitromicina
nordimet
nordic group b.v. - methotrexate - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - agenti antineoplastici - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.
enalapril e lercanidipina sandoz
sandoz s.p.a. - enalapril e lercanidipina - enalapril e lercanidipina
fenitoina hikma
hikma farmaceutica (portugal) s.a. - fenitoina - fenitoina
cibacen
viatris healthcare limited - benazepril - benazepril
nalapres
neopharmed gentili s.p.a. - lisinopril e diuretici - lisinopril e diuretici
tenkuoren
meda pharma s.p.a. - benazepril - benazepril
eliten
pharmaswiss ceska republika s.r.o. - fosinopril - fosinopril
tensogard
pharmaswiss ceska republika s.r.o. - fosinopril - fosinopril
zitromax
pfizer italia s.r.l. - azitromicina - azitromicina